Evidence map›Paper›PMID 29415672›Full record

ArticleBMC cancer2018

Incidence and histological patterns of thyroid cancer in Sri Lanka 2001-2010: an analysis of national cancer registry data.

Umesh Jayarajah, Ashan Fernando, Saumyakala Prabashani, Eshani A Fernando, Sanjeewa A Seneviratne

Abstract read
In one paragraph

Article in BMC cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Management of medullary carcinoma of the thyroid: a review.The Journal of international medical research · 2022
    Review
  5. Article
  6. Cancer services in Sri Lanka: current status and future directions.Journal of the Egyptian National Cancer Institute · 2021
    Review
  7. Article
  8. Article
  9. Thyroid Cancer Incidence in India Between 2006 and 2014 and Impact of Overdiagnosis.The Journal of clinical endocrinology and metabolism · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Umesh JayarajahDepartment of Surgery, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Ashan FernandoDepartment of Surgery, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Saumyakala PrabashaniDepartment of Surgery, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
Eshani A FernandoNational Cancer Control Programme, Ministry of Health, Colombo, Sri Lanka.
Sanjeewa A SeneviratneDepartment of Surgery, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka. sanjeewa@srg.cmb.ac.lk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAn increasing incidence of thyroid cancer is observed in many developed countries. Increasing incidence may also reflect better reporting or increased diagnostic scrutiny. We conducted this study to examine trends in thyroid cancer incidence and histological patterns in Sri Lanka.

methodsA retrospective cohort evaluation of patients with thyroid cancer during 2001-2010 was performed using population based data published from the Sri Lanka National Cancer Registry. Trends in incidence and histological patterns were analysed by age and gender.

resultsThe age-standardized incidence of thyroid cancer increased from 2.44 per 100,000 in 2001 (95% confidence interval [95% CI]: 2.21-2.67) to 5.16 per 100,000 in 2010 (95% CI: 4.85-5.47); a 2.1-fold increase (p < 0.05 for trend). A greater part of this increase is attributable to increase in incidence of papillary thyroid cancer, which increased from 1.64 to 3.61 per 100,000; a 2.2-fold increase (p < 0.05 for trend). Follicular cancer showed lesser, yet a significant increase from 0.56 to 0.95 per 100,000 (p < 0.05). Other varieties of thyroid cancer showed no significant increases in incidence. Trends in the increases in incidence of papillary cancer in females showed a much greater increase compared with males (from 2.45 to 5.60 per 100,000, a 2.28-fold increase in females compared with from 0.82 to 1.55; a 1.89-fold increase in males, p < 0.001). Highest incidence of papillary cancer was observed in 30-39-year age group, which has increased from 5.56 to 12.9 per 100,000; a 2.32-fold increase (p < 0.001).

conclusionsThe increasing incidence of thyroid cancer in Sri Lanka is predominantly due to the increasing incidence of papillary cancers. These trends may reflect increased detection and better reporting, although an inherent increase in the incidence is the likely main contributor. Further studies including tumour stage and mortality may help answer these questions.

Indexed as

Adenocarcinoma, FollicularAdultCarcinoma, PapillaryFemaleHumansIncidenceMaleMiddle AgedRegistriesRegression AnalysisRetrospective StudiesSri LankaThyroid NeoplasmsYoung AdultIncidencePapillary cancerThyroid cancer

Identifiers

PMID29415672
PMCPMC5804040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.